PlantForm: PlantForm signs agreement with Bio-Manguinhos/Fiocruz to develop a biosimilar pembrolizumab cancer drug
PlantForm Corporation, PlantPraxis Biotecnologia and Bio-Manguinhos/Fiocruz (Health Ministry of Brazil) today announced a collaborative research and development agreement to develop a biosimilar pembrolizumab for the Brazilian market.
Read full article »
PlantForm develops a molecular farming platform to produce monoclonal antibodies and therapeutic proteins for the treatment of cancer.
Read more